Navigation Links
MDS Pharma Services Launches Next Generation Phase I Study Management System
Date:7/7/2008

s fully CFR Part 11 compliant and can be used for study management and electronic data capture (EDC), either alone or in conjunction with a client-provided EDC system or paper CRFs. MDS Pharma Services offers one of the world's largest capacities for conducting early-phase clinical studies, with some 1,100 beds in five state-of-the-art clinical research facilities in North America and Europe.

About MDS Pharma Services

MDS Pharma Services is committed to delivering quality service on time. We offer a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at http://www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Pharma Services
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 2015 Carinsurancequotesinfo.com has released a new ... how to qualify for auto insurance as ... for auto insurance online, without having to follow a ... single parents can reduce their auto insurance expenses. The ... properly explained. , Clients can now visit an ...
(Date:4/24/2015)... Vancouver, BC (PRWEB) April 24, 2015 ... Albert Yuzpe, Olive Fertility co-founder and co-director, has been ... Fertility Preservation at the Evening of Hope Gala. ... to recognize Dr. Albert Yuzpe, who has been at ... past 43 years,” says Jessica Séguin, Executive Director of ...
(Date:4/24/2015)... Insuranceautoquote.info has released a new blog ... . , Lowering auto insurance prices is not ... find better offers for their financial budget. Comparing prices ... not require any registration. , Comparing quotes can ... multiple agencies that sell coverage and this means that ...
(Date:4/24/2015)... April 24, 2015 “ Opera ” was ... which features the latest and coolest technology products available to ... NewsWatch, conducted the review and shared with viewers how this ... web browsers, surfing the internet would not be in existence. ... and the Opera browser is no different. Celebrating their 20th ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Eastern Star Masonic ... new Community Room on Sunday April 26th from 1:30-3:00 pm. ... to attend the ribbon cutting and grand opening of the ... will be on hand to offer tours to anyone who ... community. , The new community room will be available for ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2
... Data Can Be Integrated with Other Sales & ... Key Performance Indicators, Dynamic Graphs, And Custom Metrics ... leader in pharmaceutical data analysis and reporting solutions, ... within InView, the company,s graphical interactive portal for ...
... April 29 New analyses of data from ... beta-1b), sponsored by Bayer HealthCare Pharmaceuticals, were presented ... Annual Meeting. The study results showed that ... participants with multiple sclerosis (MS) were more likely ...
... warns more deaths are likely , , WEDNESDAY, April 29 ... become the first U.S. fatality in the spreading swine ... Dr. Richard Besser, acting director of the U.S. Centers ... other details on the case were immediately available, according ...
... Diluted Earnings per Share were $0.89, , Consistent ... Excluding Certain Significant Items, Increased 1% to $0.95- Worldwide ... , Increased 2%, Excluding the Impact of Foreign Exchange ... , Exchange, was Driven by Increases of 23% ...
... vs. $25.2 million - Increase of 34%Record Quarterly Diluted EPS: $0.17 vs. ... OWINGS MILLS, Md., April 29 Medifast, Inc. (NYSE: MED ... 31, 2009. First Quarter highlights included: , , ... quarter revenues increased 34% compared to 2008 to $33.7 million; , ...
... consider healthy hearing for spring 2009 , ... Stäfa, ... spring marks an opportunity for Americans to refresh and revitalize themselves. ... global initiative to inform and educate the public about the importance ...
Cached Medicine News:Health News:Archi-Tech InView Now Supports Managed Care Data, Offering an Interactive Dashboard for On-Demand Sales Planning and Reporting 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 3Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 4Health News:U.S. Reports First Swine Flu Death 2Health News:U.S. Reports First Swine Flu Death 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 2Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 4Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 5Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 6Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 7Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 8Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 9Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 10Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 11Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 12Health News:Medifast Reports Record First Quarter 2009 Financial Results 2Health News:Medifast Reports Record First Quarter 2009 Financial Results 3Health News:Medifast Reports Record First Quarter 2009 Financial Results 4Health News:Medifast Reports Record First Quarter 2009 Financial Results 5Health News:Medifast Reports Record First Quarter 2009 Financial Results 6Health News:Medifast Reports Record First Quarter 2009 Financial Results 7Health News:Medifast Reports Record First Quarter 2009 Financial Results 8Health News:Medifast Reports Record First Quarter 2009 Financial Results 9Health News:This Spring, Hear the World 2Health News:This Spring, Hear the World 3
(Date:4/23/2015)... 24, 2015  AbbVie (NYSE: ABBV ) has ... has accepted its New Drug Application (NDA) and granted ... antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin ... with chronic genotype 4 (GT4) hepatitis C virus (HCV) ... interferon-free therapy being evaluated by the FDA for patients ...
(Date:4/23/2015)... Health Canada is working with the Canadian manufacturers of ... regarding the risk of serious cardiovascular side effects (e.g., ... at high doses (at or above 2400 mg/day). This ... Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used ... The majority of ibuprofen products in Canada ...
(Date:4/23/2015)... BOULDER, Colo. , Apr. 23, 2015 /PRNewswire/ ... engineers, manufactures, and distributes state-of-the art equipment and ... specialization in commercial indoor cannabis cultivation, will host ... on Monday, April 27, 2015, at 4:15 PM ... The conference call will be listen-in ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3
... best value in high performance electronic pipetting!, ... design reduce hand fatigue and strain , ... ejector , Color coding for easy volume ... greater performance use Hamilton AdvanTip Low Retention ...
Inquire...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
... The StaRRsed Compact is a system ... human blood samples. This rate may ... patients therapy. The sedimentation rate is ... hence is typically used in high-volume ...
Medicine Products: